Using theranostics to pinpoint and treat the earliest, preclinical symptoms of Alzheimer's disease, researchers say their new method shows promise in stopping the progression of Alzheimer's pathologies before the onset of irreversible neural damage.
from Neuroscience News https://ift.tt/2hW1wZ0
Comments
Post a Comment